|
2024-06-25 |
2024-06-24 |
V
Vente
|
Aranda Richard
Chief Medical Officer
Dirigeant
|
1 908
-1.0%
0,66
1 260 USD
|
1 908
-1.0%
|
0,66
|
1 260 USD
|
|
|
2024-06-24 |
2024-06-21 |
A
Achat
|
Hasnain Faheem
President & CEO
Administrateur exécutif
|
372 000
+7.4%
0,67
250 282 USD
|
372 000
+7.4%
|
0,67
|
250 282 USD
|
|
|
2024-06-20 |
2024-06-18 |
A
Achat
|
Giraudo Bryan
COO/CFO
Dirigeant
|
100 000
+26.3%
0,59
59 110 USD
|
100 000
+26.3%
|
0,59
|
59 110 USD
|
|
|
2024-06-20 |
2024-06-17 |
A
Achat
|
Smith Robert Paul JR
Chief Commercial Officer
Dirigeant
|
25 000
+inf%
0,60
15 050 USD
|
25 000
+inf%
|
0,60
|
15 050 USD
|
|
|
2024-03-28 |
2024-03-27 |
V
Vente
|
Hasnain Faheem
President & CEO
Administrateur exécutif
|
23 172
-16.2%
1,16
26 773 USD
|
23 172
-16.2%
|
1,16
|
26 773 USD
|
|
|
2024-03-28 |
2024-03-27 |
V
Vente
|
Christian Waage
EVP, Tech Ops and Admin
Dirigeant
|
6 430
-1.1%
1,16
7 430 USD
|
6 430
-1.1%
|
1,16
|
7 430 USD
|
|
|
2024-03-28 |
2024-03-27 |
V
Vente
|
Giraudo Bryan
COO/CFO
Dirigeant
|
6 430
-6.5%
1,16
7 431 USD
|
6 430
-6.5%
|
1,16
|
7 431 USD
|
|
|
2024-03-19 |
2024-03-18 |
V
Vente
|
Peterson Caryn
EVP, Regulatory Affairs
Dirigeant
|
4 018
-7.5%
1,33
5 343 USD
|
4 018
-7.5%
|
1,33
|
5 343 USD
|
|
|
2024-03-19 |
2024-03-18 |
V
Vente
|
Aranda Richard
Chief Medical Officer
Dirigeant
|
4 018
-2.0%
1,33
5 342 USD
|
4 018
-2.0%
|
1,33
|
5 342 USD
|
|
|
2023-11-17 |
2023-11-15 |
A
Achat
|
Milligan Sandra
Administrateur non-exécutif
|
32 000
+inf%
0,79
25 213 USD
|
32 000
+inf%
|
0,79
|
25 213 USD
|
|
|
2023-11-14 |
2023-11-13 |
A
Achat
|
Giraudo Bryan
COO/CFO
Dirigeant
|
200 000
+111.1%
0,56
112 880 USD
|
200 000
+111.1%
|
0,56
|
112 880 USD
|
|
|
2023-06-26 |
2023-06-22 |
V
Vente
|
Aranda Richard
Chief Medical Officer
Dirigeant
|
1 814
-0.9%
1,29
2 340 USD
|
1 814
-0.9%
|
1,29
|
2 340 USD
|
|
|
2023-04-05 |
2023-04-04 |
A
Achat
|
Giraudo Bryan
COO/CFO
Dirigeant
|
55 000
+77.5%
1,02
56 095 USD
|
55 000
+77.5%
|
1,02
|
56 095 USD
|
|
|
2023-03-22 |
2023-03-22 |
A
Achat
|
Hasnain Faheem
President & CEO
Administrateur exécutif
|
440 500
+10.9%
1,14
503 580 USD
|
440 500
+10.9%
|
1,14
|
503 580 USD
|
|
|
2023-03-22 |
2023-03-21 |
A
Achat
|
Hasnain Faheem
President & CEO
Administrateur exécutif
|
269 389
+7.1%
1,20
322 324 USD
|
269 389
+7.1%
|
1,20
|
322 324 USD
|
|
|
2023-03-22 |
2023-03-20 |
A
Achat
|
Giraudo Bryan
COO/CFO
Dirigeant
|
50 000
+238.2%
0,97
48 435 USD
|
50 000
+238.2%
|
0,97
|
48 435 USD
|
|
|
2023-03-22 |
2023-03-20 |
A
Achat
|
Hasnain Faheem
President & CEO
Administrateur exécutif
|
168 683
+4.7%
1,03
174 486 USD
|
168 683
+4.7%
|
1,03
|
174 486 USD
|
|
|
2023-03-22 |
2023-03-20 |
A
Achat
|
Christian Waage
EVP, Tech Ops and Admin
Dirigeant
|
18 500
+133.2%
1,20
22 145 USD
|
18 500
+133.2%
|
1,20
|
22 145 USD
|
|
|
2023-03-20 |
2023-03-16 |
V
Vente
|
Carter Laura
Chief Scientific Officer
Dirigeant
|
6 029
-7.3%
1,10
6 620 USD
|
6 029
-7.3%
|
1,10
|
6 620 USD
|
|
|
2023-03-20 |
2023-03-16 |
V
Vente
|
Peterson Caryn
EVP, Regulatory Affairs
Dirigeant
|
7 564
-12.3%
1,10
8 305 USD
|
7 564
-12.3%
|
1,10
|
8 305 USD
|
|
|
2023-03-20 |
2023-03-16 |
V
Vente
|
Aranda Richard
Chief Medical Officer
Dirigeant
|
7 563
-3.7%
1,10
8 304 USD
|
7 563
-3.7%
|
1,10
|
8 304 USD
|
|
|
2022-10-25 |
2022-10-24 |
V
Vente
|
Carter Laura
Chief Scientific Officer
Dirigeant
|
4 876
-5.6%
12,07
58 868 USD
|
4 876
-5.6%
|
12,07
|
58 868 USD
|
|
|
2022-10-25 |
2022-10-24 |
V
Vente
|
Aranda Richard
Chief Medical Officer
Dirigeant
|
4 757
-2.3%
12,07
57 431 USD
|
4 757
-2.3%
|
12,07
|
57 431 USD
|
|
|
2022-10-25 |
2022-10-24 |
V
Vente
|
Peterson Caryn
EVP, Regulatory Affairs
Dirigeant
|
4 757
-7.2%
12,07
57 431 USD
|
4 757
-7.2%
|
12,07
|
57 431 USD
|
|
|
2022-07-15 |
2022-07-15 |
A
Achat
|
Giraudo Bryan
COO/CFO
Dirigeant
|
13 869
+194.8%
7,21
99 995 USD
|
13 869
+194.8%
|
7,21
|
99 995 USD
|
|
|
2022-07-15 |
2022-07-15 |
A
Achat
|
Christian Waage
EVP, Tech Ops and Admin
Dirigeant
|
6 934
+99.7%
7,21
49 994 USD
|
6 934
+99.7%
|
7,21
|
49 994 USD
|
|
|
2022-07-15 |
2022-07-15 |
A
Achat
|
Hasnain Faheem
President & CEO
Administrateur exécutif
|
138 696
+4.0%
7,21
999 998 USD
|
138 696
+4.0%
|
7,21
|
999 998 USD
|
|
|
2022-07-15 |
2022-07-15 |
A
Achat
|
Carter Laura
Chief Scientific Officer
Dirigeant
|
6 934
+8.6%
7,21
49 994 USD
|
6 934
+8.6%
|
7,21
|
49 994 USD
|
|
|
2022-07-05 |
2022-07-01 |
V
Vente
|
Carter Laura
Chief Scientific Officer
Dirigeant
|
8 808
-9.9%
8,25
72 648 USD
|
8 808
-9.9%
|
8,25
|
72 648 USD
|
|
|
2022-06-23 |
2022-06-22 |
V
Vente
|
Aranda Richard
Chief Medical Officer
Dirigeant
|
1 778
-0.8%
6,88
12 233 USD
|
1 778
-0.8%
|
6,88
|
12 233 USD
|
|
|
2022-05-05 |
2022-05-04 |
V
Vente
|
Carter Laura
Chief Scientific Officer
Dirigeant
|
1 262
-1.4%
7,20
9 086 USD
|
1 262
-1.4%
|
7,20
|
9 086 USD
|
|
|
2022-03-24 |
2022-03-23 |
V
Vente
|
Hasnain Faheem
President & CEO
Administrateur exécutif
|
19 035
-11.7%
8,92
169 697 USD
|
19 035
-11.7%
|
8,92
|
169 697 USD
|
|
|
2022-03-24 |
2022-03-23 |
V
Vente
|
Giraudo Bryan
COO/CFO
Dirigeant
|
10 722
-9.8%
8,92
95 587 USD
|
10 722
-9.8%
|
8,92
|
95 587 USD
|
|
|
2022-03-24 |
2022-03-23 |
V
Vente
|
Christian Waage
EVP, Tech Ops and Admin
Dirigeant
|
10 722
-1.8%
8,92
95 587 USD
|
10 722
-1.8%
|
8,92
|
95 587 USD
|
|
|
2022-03-17 |
2022-03-16 |
V
Vente
|
Peterson Caryn
EVP, Regulatory Affairs
Dirigeant
|
6 279
-8.7%
8,28
51 978 USD
|
6 279
-8.7%
|
8,28
|
51 978 USD
|
|
|
2022-03-17 |
2022-03-16 |
V
Vente
|
Carter Laura
Chief Scientific Officer
Dirigeant
|
5 002
-5.2%
8,28
41 407 USD
|
5 002
-5.2%
|
8,28
|
41 407 USD
|
|
|
2022-03-17 |
2022-03-16 |
V
Vente
|
Aranda Richard
Chief Medical Officer
Dirigeant
|
6 278
-2.9%
8,28
51 976 USD
|
6 278
-2.9%
|
8,28
|
51 976 USD
|
|
|
2021-10-26 |
2021-10-25 |
V
Vente
|
Aranda Richard
Chief Medical Officer
Dirigeant
|
2 377
-1.1%
12,25
29 118 USD
|
2 377
-1.1%
|
12,25
|
29 118 USD
|
|
|
2021-10-26 |
2021-10-25 |
V
Vente
|
Peterson Caryn
EVP, Regulatory Affairs
Dirigeant
|
2 377
-3.2%
12,25
29 118 USD
|
2 377
-3.2%
|
12,25
|
29 118 USD
|
|
|
2021-10-26 |
2021-10-25 |
V
Vente
|
Carter Laura
Chief Scientific Officer
Dirigeant
|
2 377
-2.4%
12,25
29 118 USD
|
2 377
-2.4%
|
12,25
|
29 118 USD
|
|
|
2021-03-25 |
2021-03-23 |
V
Vente
|
Salter-Cid Luisa
Chief Scientific Officer
Dirigeant
|
5 491
-2.6%
9,48
52 052 USD
|
5 491
-2.6%
|
9,48
|
52 052 USD
|
|
|
2021-03-25 |
2021-03-23 |
V
Vente
|
Giraudo Bryan
Chief Financial Officer
Dirigeant
|
5 490
-4.8%
9,48
52 046 USD
|
5 490
-4.8%
|
9,48
|
52 046 USD
|
|
|
2021-03-25 |
2021-03-23 |
V
Vente
|
Christian Waage
EVP & General Counsel
Dirigeant
|
5 490
-0.9%
9,48
52 051 USD
|
5 490
-0.9%
|
9,48
|
52 051 USD
|
|
|
2020-10-14 |
2020-10-14 |
A
Achat
|
Giraudo Bryan
Chief Financial Officer
Dirigeant
|
3 000
+72.8%
10,01
30 036 USD
|
3 000
+72.8%
|
10,01
|
30 036 USD
|
|
|
2020-10-14 |
2020-10-14 |
A
Achat
|
Hasnain Faheem
Administrateur non-exécutif
|
96 520
+2.9%
10,36
999 995 USD
|
96 520
+2.9%
|
10,36
|
999 995 USD
|
|
|
2020-10-14 |
2020-10-14 |
A
Achat
|
Christian Waage
EVP & General Counsel
Dirigeant
|
2 500
+56.1%
9,53
23 818 USD
|
2 500
+56.1%
|
9,53
|
23 818 USD
|
|
|
2020-06-23 |
2020-06-23 |
A
Achat
|
Giraudo Bryan
Chief Financial Officer
Dirigeant
|
2 000
+94.3%
12,96
25 922 USD
|
2 000
+94.3%
|
12,96
|
25 922 USD
|
|
|
2019-12-31 |
2019-12-30 |
V
Vente
|
Dupont Jakob
Chief Medical Officer
Dirigeant
|
40 000
-100.0%
15,00
600 004 USD
|
40 000
-100.0%
|
15,00
|
600 004 USD
|
|
|
2019-12-31 |
2019-12-27 |
V
Vente
|
Dupont Jakob
Chief Medical Officer
Dirigeant
|
1 994
-100.0%
15,81
31 534 USD
|
1 994
-100.0%
|
15,81
|
31 534 USD
|
|
|
2019-09-27 |
2019-09-27 |
A
Achat
|
Christian Waage
EVP & General Counsel
|
1 000
+29.0%
16,65
16 654 USD
|
1 000
+29.0%
|
16,65
|
16 654 USD
|
|
|
2019-09-27 |
2019-09-27 |
A
Achat
|
Gujrathi Sheila
President & CEO
Administrateur exécutif
|
10 000
+0.2%
16,80
167 980 USD
|
10 000
+0.2%
|
16,80
|
167 980 USD
|
|
|
2019-09-27 |
2019-09-27 |
A
Achat
|
Hasnain Faheem
|
10 000
+0.3%
16,80
167 980 USD
|
10 000
+0.3%
|
16,80
|
167 980 USD
|
|
|
2019-09-26 |
2019-09-26 |
A
Achat
|
Giraudo Bryan
Chief Financial Officer
|
1 121
+112.1%
16,78
18 810 USD
|
1 121
+112.1%
|
16,78
|
18 810 USD
|
|
|
2019-09-23 |
2019-09-20 |
V
Vente
|
Omega Fund V, L.P.
Actionnaire important
|
183 607
-2.7%
21,96
4 032 561 USD
|
183 607
-2.7%
|
21,96
|
4 032 561 USD
|
|
|
2019-09-18 |
2019-09-18 |
V
Vente
|
Omega Fund V, L.P.
Former director.
Actionnaire important
|
45 600
-0.7%
21,88
997 637 USD
|
45 600
-0.7%
|
21,88
|
997 637 USD
|
|
|
2019-09-18 |
2019-09-17 |
V
Vente
|
Omega Fund V, L.P.
Former director.
Actionnaire important
|
23 400
-0.3%
21,62
505 791 USD
|
23 400
-0.3%
|
21,62
|
505 791 USD
|
|
|
2019-09-18 |
2019-09-16 |
V
Vente
|
Omega Fund V, L.P.
Former director.
Actionnaire important
|
13 213
-0.2%
21,52
284 331 USD
|
13 213
-0.2%
|
21,52
|
284 331 USD
|
|
|
2019-09-12 |
2019-09-11 |
V
Vente
|
Omega Fund V, L.P.
Actionnaire important
|
80 403
-1.2%
21,31
1 713 629 USD
|
80 403
-1.2%
|
21,31
|
1 713 629 USD
|
|
|
2019-09-12 |
2019-09-10 |
V
Vente
|
Omega Fund V, L.P.
Actionnaire important
|
32 373
-0.5%
21,00
679 865 USD
|
32 373
-0.5%
|
21,00
|
679 865 USD
|
|
|
2019-09-09 |
2019-09-06 |
V
Vente
|
Omega Fund V, L.P.
Actionnaire important
|
8 700
-0.1%
21,51
187 103 USD
|
8 700
-0.1%
|
21,51
|
187 103 USD
|
|
|
2019-09-09 |
2019-09-05 |
V
Vente
|
Omega Fund V, L.P.
Actionnaire important
|
12 704
-0.2%
21,60
274 434 USD
|
12 704
-0.2%
|
21,60
|
274 434 USD
|
|
|
2019-08-29 |
2019-08-29 |
V
Vente
|
Salter-Cid Luisa
Chief Scientific Officer
Dirigeant
|
26 252
-17.5%
20,09
527 319 USD
|
26 252
-17.5%
|
20,09
|
527 319 USD
|
|
|
2019-08-29 |
2019-08-28 |
V
Vente
|
Salter-Cid Luisa
Chief Scientific Officer
Dirigeant
|
23 748
-13.6%
19,65
466 724 USD
|
23 748
-13.6%
|
19,65
|
466 724 USD
|
|
|
2019-06-03 |
2019-05-30 |
A
Achat
|
Giraudo Bryan
Chief Financial Officer
|
1 000
+inf%
18,70
18 700 USD
|
1 000
+inf%
|
18,70
|
18 700 USD
|
|
|
2019-02-12 |
2019-02-12 |
A
Achat
|
Christian Waage
EVP & General Counsel
Dirigeant
|
1 550
+0.3%
16,00
24 800 USD
|
1 550
+0.3%
|
16,00
|
24 800 USD
|
|
|
2019-02-12 |
2019-02-12 |
A
Achat
|
Cox Russell J.
Administrateur non-exécutif
|
7 200
+inf%
16,00
115 200 USD
|
7 200
+inf%
|
16,00
|
115 200 USD
|
|
|
2019-02-12 |
2019-02-12 |
A
Achat
|
Giraudo Bryan
Chief Financial Officer
Dirigeant
|
6 000
+33.6%
16,00
96 000 USD
|
6 000
+33.6%
|
16,00
|
96 000 USD
|
|
